[Antithrombotic treatment in atrial fibrillation and cardiovascular disease]
Tidsskr Nor Laegeforen
.
2014 May 13;134(9):923.
doi: 10.4045/tidsskr.13.1618.
[Article in Norwegian]
Authors
Arnljot Tveit
,
Sigrun Halvorsen
,
Eivind Berge
,
Torunn Sætre
PMID:
24828714
DOI:
10.4045/tidsskr.13.1618
No abstract available
MeSH terms
Atrial Fibrillation / drug therapy*
Cardiovascular Diseases / drug therapy*
Fibrinolytic Agents / therapeutic use*
Humans
Norway
Practice Guidelines as Topic
Substances
Fibrinolytic Agents